跳至主要内容
临床试验/CTRI/2025/01/079807
CTRI/2025/01/079807尚未招募3 期

Randomized Controlled Clinical Study to Evaluate Efficacy of Siddhartak Udvartan with Bakuchi Ghan in Shvitra

Mohd Khalid Abdul Aziz Ambekar1 个研究点 分布在 1 个国家目标入组 156 人开始时间: 2025年2月15日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
156
试验地点
1
主要终点
Shwet Mandal

研究概览

简要总结

Vitiligo affects about 0.5%-1% of the total worldwide population.The highest incidence is recorded in India and Mexico. The prevalence of Vitiligo in India is between 0.25% to 4% of dermatology OPD. In Ayurveda Bakuchi (Psoralea Corylifolia) is the main herb in treating  Shvitra (Vitiligo). In many patients external use of Bakuchi gives Sunburn type effects, so patients try to avoid its use. Considering above factor present study is undertaken to search alternate to Bakuchi. In present study I have taken "Siddhartak Snan Kalp "(Ref-Charak Chikitsa 7/91-92 Chakrapani tika) for external use in "Udvartan " form.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
16.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients fulfilling the criteria of diagnosis of Shvitra irrespective of sex,religion and economic status.
  • 2.Newly developed patches or macules(within one year).
  • 3.Patients of Shvitra having VASI Score less than 50%.

排除标准

  • 1.Psychotic patients.
  • 2.Whole body affected with Shvitra.
  • 3.Shvitra on lips,on palms of hand,sole of feet and white haired patches.
  • 4.Secondary to burn.
  • 5.On private parts.
  • 6.Pregnancy and lactating mother.
  • 7.Patients having hereditary Shvitra.
  • 8.Post injury Shvitra 9.Patient receiving Allopathic or other treatment for Shvitra.
  • 10.Patient having hypersensitive skin to any external application.

结局指标

主要结局

Shwet Mandal

时间窗: follow up of all patients will be taken after every 15 days for three months

1) Colour of lesion-

时间窗: follow up of all patients will be taken after every 15 days for three months

Grade- 0-Normal

时间窗: follow up of all patients will be taken after every 15 days for three months

1-Black

时间窗: follow up of all patients will be taken after every 15 days for three months

2-Red

时间窗: follow up of all patients will be taken after every 15 days for three months

3-Pink

时间窗: follow up of all patients will be taken after every 15 days for three months

4-White

时间窗: follow up of all patients will be taken after every 15 days for three months

2) Shape of lesion-

时间窗: follow up of all patients will be taken after every 15 days for three months

Grade- 0-Totally cured

时间窗: follow up of all patients will be taken after every 15 days for three months

1-Reduced to some

时间窗: follow up of all patients will be taken after every 15 days for three months

extend

时间窗: follow up of all patients will be taken after every 15 days for three months

2-No change in

时间窗: follow up of all patients will be taken after every 15 days for three months

shape

时间窗: follow up of all patients will be taken after every 15 days for three months

次要结局

  • Objective Criteria
  • Investigations
  • Subjective Criteria(1)Kandu(Itching)-)
  • 3) Daha-(Grade-)

研究者

发起方
Mohd Khalid Abdul Aziz Ambekar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Mohd Khalid Abdul Aziz Ambekar

SVNH Ayurved College

研究点 (1)

Loading locations...

相似试验